Authors: VAUGHAN TL FARROW DC HANSTEN PD CHOW WH GAMMON MD RISCH HA STANFORD JL SCHOENBERG JB MAYNE ST ROTTERDAM H DUBROW R AHSAN H WEST AB BLOT WJ FRAUMENI JF

Citation: Tl. Vaughan et al., RISK OF ESOPHAGEAL AND GASTRIC ADENOCARCINOMAS IN RELATION TO USE OF CALCIUM-CHANNEL BLOCKERS, ASTHMA DRUGS, AND OTHER MEDICATIONS THAT PROMOTE GASTROESOPHAGEAL REFLUX, Cancer epidemiology, biomarkers & prevention, 7(9), 1998, pp. 749-756

Authors: FARROW DC VAUGHAN TL HANSTEN PD STANFORD JL RISCH HA GAMMON MD CHOW WH DUBROW R AHSAN H MAYNE ST SCHOENBERG JB WEST AB ROTTERDAM H FRAUMENI JF BLOT WJ

Citation: Dc. Farrow et al., USE OF ASPIRIN AND OTHER NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND RISKOF ESOPHAGEAL AND GASTRIC-CANCER, Cancer epidemiology, biomarkers & prevention, 7(2), 1998, pp. 97-102

Authors: SCHOLES D STERGACHIS A PENNA PM NORMAND EH HANSTEN PD

Citation: D. Scholes et al., NONSTEROIDAL ANTIINFLAMMATORY DRUG DISCONTINUATION IN PATIENTS WITH OSTEOARTHRITIS, Journal of rheumatology, 22(4), 1995, pp. 708-712

Authors: HORN JR HANSTEN PD

Citation: Jr. Horn et Pd. Hansten, DRUG-INTERACTIONS WITH ANTIBACTERIAL AGENTS, Journal of family practice, 41(1), 1995, pp. 81-90

Authors: HORN JR HANSTEN PD

Citation: Jr. Horn et Pd. Hansten, PITFALLS IN REPORTING DRUG-INTERACTIONS - COMMENT, The Annals of pharmacotherapy, 27(12), 1993, pp. 1545-1546